Whoop, a leader in human performance technology, has successfully closed a significant funding round and is now setting its sights on an Initial Public Offering (IPO). The company's recent Series G funding round, which raised $575 million, places its valuation at an impressive $10.1 billion, signaling strong investor confidence in its innovative approach to health and wellness.
This strategic financial move, coupled with the company's robust growth and operational profitability, positions Whoop for a public market debut. With key partnerships and a clear vision for expanding its impact on human longevity and performance, the company is poised to continue its upward trajectory in the competitive health technology sector.
Strategic Funding Paves Way for Public Offering
Whoop recently concluded its Series G funding round, securing $575 million, which propelled the company's valuation to $10.1 billion. This substantial capital infusion is anticipated to be the final private funding round before Whoop pursues an IPO. CEO Will Ahmed emphasized that the company achieved positive operating cash flow in 2025, underscoring its financial health and readiness for the public market. The funding round saw participation from a diverse group of investors, including Collaborative Fund, 2PointZero Group, Qatar Investment Authority, and prominent healthcare entities like Abbott and Mayo Clinic. This strategic backing from healthcare leaders highlights Whoop's growing recognition as a significant player in the longevity and wellness space, moving beyond traditional fitness tracking into clinical health integration.
The successful funding round not only strengthens Whoop's balance sheet but also solidifies its position among the world's most valuable private companies. The involvement of major healthcare players like Abbott and Mayo Clinic signals a strategic pivot for Whoop, as it increasingly aligns its technology with broader health and longevity initiatives. This influx of capital and strategic partnerships provides Whoop with a robust foundation to expand its research and development, enhance its product offerings, and scale its operations in preparation for an eventual public offering. The company's strong financial performance, with 103% year-over-year growth in bookings and a $1.1 billion bookings run rate by the end of 2025, further reinforces its attractiveness to potential public investors and validates its business model in a rapidly evolving market.
Innovating Health Tracking and Performance Optimization
Founded in 2012 by Will Ahmed, Whoop distinguishes itself in the wearable technology market by focusing on comprehensive physiological data rather than notifications. Its devices track crucial metrics such as physical recovery, sleep patterns, and daily strain, providing users with deep insights to optimize their performance and well-being. Recent innovations, including the launch of Whoop 5.0 and Whoop MG, demonstrate the company's commitment to advancing its technology. Notably, the Whoop MG model has received FDA clearance for medical-grade ECG and blood pressure monitoring, marking a significant step towards integrating its technology into clinical health applications. Additionally, the platform utilizes Whoop Coach AI to deliver personalized training recommendations, leveraging individual user data for tailored fitness and recovery guidance.
Whoop operates on a subscription-based model, where the wearable device is provided without an upfront cost upon membership enrollment, with an annual fee of $239 for a standard membership as of early 2026. This model has contributed to a growing user base, with 2.5 million members and substantial growth in bookings. The company continues to explore new frontiers in health sensing, constantly evaluating different biometric tracking locations and capabilities beyond conventional health monitoring. This continuous innovation, particularly the integration of medical-grade features and AI-driven personalized insights, positions Whoop as a key player in the future of health technology, aiming to enhance human performance and overall healthspan through advanced data analysis and user-centric design.